Senior insider sale
PRESIDENT & CFO at XENON PHARMACEUTICALS INC. — senior position signals high conviction
$1.00M
25K shares
What this filing means
MORTIMER IAN plans to sell 25K shares of XENON PHARMACEUTICALS INC. valued at approximately $1.00M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/1/2025ACC: 0001193125-25-227196
Officer· PRESIDENT & CFO
Since Sep 2019
25K
Shares to sell
$1.00M
Approx. market value
25K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exercise of Options
Cash
10/1/2025
25KTotal acquired25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2025 | Exercise of Options Cash | 25K | — |
| Total | 25K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
25K
Market value
$1.00M
10/1/2025
Total
Units
25K
Value
$1.00M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/1/2025 | 25K | $1.00M | NASDAQ | Planned |
| Total | 25K | $1.00M | ||